This company invites all interested, both current investors and potential investors to participate in this event, ask questions directly on this page before the event starts and upvote those questions you would like addressed.
The company will address as many questions as possible, and focus on those questions most wanted by investors.
When do you expect to receive the answer for the resubmitted EIC Accelerator grant of 60 mDKK?
How close are we in terms of getting to product market fit, i.e. having very clearly defined customer segments where we understand their pain points/needs, and the customers agree that we have a superior product, which solve their needs and where they are willing to pay our asking price?
Can you share more details about the unit economics, e.g. gross margin, cost of acquisition, life time value etc.?
Within a short time span we saw the chairman and the CFO resigning. Can you address what is going on?
What is the current status of our collaboration with RoX Health in Germany? Could you provide an update on the progress and any significant developments?
Could you provide additional information about the current grant application, with a particular focus on the EIC?
According to the recent release about the 2024 commercial plan, focus is on UK, but you first expect to have a UK product ready in Q3 2024, so what are the commercial activities that you are planning for in Q1-Q3 2024 and how will you handle the activities, local office, agents..?
Can you provide an Update on number of licenses sold so far, number of usages and also number of municipalities?
How much capital is expected to be required to get to breakeven, and what is managements current expectations in terms of when breakeven realistically can be achieved?
What is for 2024 the main objectives to take the company one big step closer to an established business?
When Can we expect to begin to see some revenue Numbers and guidance on KPIs going forward?